Growth Metrics

Ginkgo Bioworks Holdings (DNA) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to $9.9 million.

  • Ginkgo Bioworks Holdings' Cash from Financing Activities rose 223720.43% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year increase of 53496.31%. This contributed to the annual value of -$1.7 million for FY2024, which is 4592.66% up from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Cash from Financing Activities of $9.9 million as of Q3 2025, which was up 223720.43% from -$98000.0 recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Cash from Financing Activities ranged from a high of $1.5 billion in Q3 2021 and a low of -$11.0 million during Q4 2021
  • Moreover, its 5-year median value for Cash from Financing Activities was -$433000.0 (2021), whereas its average is $86.0 million.
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Cash from Financing Activities crashed by 583709.68% in 2021 and then skyrocketed by 223720.43% in 2025.
  • Quarter analysis of 5 years shows Ginkgo Bioworks Holdings' Cash from Financing Activities stood at -$11.0 million in 2021, then skyrocketed by 985.29% to $97.8 million in 2022, then crashed by 100.65% to -$632000.0 in 2023, then skyrocketed by 67.88% to -$203000.0 in 2024, then soared by 4995.57% to $9.9 million in 2025.
  • Its Cash from Financing Activities was $9.9 million in Q3 2025, compared to -$98000.0 in Q2 2025 and -$207000.0 in Q1 2025.